Patents Assigned to Boston Scientific Neuromodulation Corporation
  • Patent number: 11904171
    Abstract: A system for adjusting neuromodulation parameters used by a neuromodulator operably connected to a plurality of electrodes to modulate a neural target, may comprise a translation trigger detector configured to determine that a translation trigger has occurred, a first parameter setting storage configured to store first parameter settings for use by the neuromodulator to modulate the neural target, and a neuromodulation parameter translator. The neuromodulation parameter translator may be operably connected to the translation trigger detector to automatically translate the first parameter settings into a second parameter settings in response to determining the translation trigger has occurred, and replace the first parameter settings with the second parameter settings, or store the second parameter settings in a second parameter setting storage.
    Type: Grant
    Filed: August 30, 2021
    Date of Patent: February 20, 2024
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Richard Mustakos, Stephen Carcieri, Chirag Shah, Peter J. Yoo
  • Patent number: 11904168
    Abstract: An example of a system may include electrodes on at least one lead configured to be operationally positioned for use in modulating a volume of neural tissue, where the neural tissue has an activation function. The system may further include a neural modulation generator configured to deliver energy using at least some electrodes to generate a modulation field within the volume of neural tissue. The neural modulation generator may be configured to use a programmed modulation parameter set to generate the modulation field. The programmed modulation parameter set having values selected to control energy delivery using the at least some electrodes to achieve an objective function specific to the activation function of the volume of neural tissue to promote uniformity of a response to the modulation field in the volume of neural tissue along a span of the at least one lead.
    Type: Grant
    Filed: September 12, 2019
    Date of Patent: February 20, 2024
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Jordi Parramon, Bradley Lawrence Hershey, Michael A. Moffitt, Changfang Zhu
  • Patent number: 11890470
    Abstract: An example of a system for programming a neurostimulator may include a storage device and a user interface. The storage device may be configured to store waveform building blocks. The user interface may include a display screen, a user input device, and an interface control circuit. The interface control circuit may include a waveform composer configured to allow for composition of one of more building blocks and composition of a pattern of neurostimulation pulses using selected one or more waveform building blocks. The waveform composer may include a library controller and waveform building block editors. The library controller may be configured to display a library management area on the screen. The displayed library management area allows a user to manage the stored waveform building blocks. The waveform building block editors may each be configured to allow the user to compose a type of the waveform building blocks.
    Type: Grant
    Filed: April 28, 2022
    Date of Patent: February 6, 2024
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: David Ernest Wechter, David Lubensky, Brian Hoffer
  • Patent number: 11890465
    Abstract: Methods and systems for providing neuromodulation therapy are disclosed. The systems include an Implantable Pulse Generator (IPG) or External Trial Stimulator (ETS) that is capable of sensing an Evoked Compound Action Potential (ECAP), and (perhaps in conjunction with an external device) is capable of adjusting a stimulation program while based on the sensed ECAP. The stimulation program may include a pre-pulse component that may be adjusted based on the sensed ECAP. Moreover, stimulation may be applied to neural elements timed to coincide with the arrival of ECAPs at those neural elements. The stimulation may enhance or suppress activation of those neural elements.
    Type: Grant
    Filed: March 6, 2019
    Date of Patent: February 6, 2024
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Tianhe Zhang, Rosana Esteller, Natalie Brill
  • Patent number: 11890480
    Abstract: A neuromodulation system for use with electrodes to modulate a volume of neural tissue may include a waveform generator and a controller. The waveform generator may be configured to be electrically connected to the electrodes and provide an electrical waveform through at least some of the electrodes to provide a neuromodulation therapy. The controller may be configured to use a program to control the waveform generator to deliver a neuromodulation therapy by delivering both a fast-acting sub-perception neuromodulation and a slow-acting sub-perception neuromodulation. The fast-acting neuromodulation has a wash-in transition period less than a first time duration, and the slow-acting sub-perception neuromodulation has a wash-in transition period more than a second time duration, the second time duration being longer than the first time duration.
    Type: Grant
    Filed: January 13, 2020
    Date of Patent: February 6, 2024
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventor: Michael A. Moffitt
  • Patent number: 11883664
    Abstract: Systems and methods for managing pain in patient are described. A system may include sensors configured to sense physiological or functional signals, and a pain analyzer to generate signal metrics from the physiological or functional signals. The pain analyzer also generates weight factors corresponding to the signal metrics. The weight factors may indicate the signal metrics reliability in representing an intensity of the pain. The pain analyzer generates a pain score using a plurality of signal metrics and a plurality of weight factors. The pain score may be output to a user or a process. The system may additionally include an electrostimulator to generate and deliver closed-loop pain therapy according to the pain score.
    Type: Grant
    Filed: June 23, 2022
    Date of Patent: January 30, 2024
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Pramodsingh Hirasingh Thakur, Jianwen Gu, Bryan Allen Clark, David J. Ternes, David L. Perschbacher, James John Kleinedler, Elizabeth Mary Annoni
  • Patent number: 11883647
    Abstract: A lead assembly and a method of making a lead are provided. The method of making a multi-contact lead assembly comprises placing monofilament placed in the void spaces not occupied by the plurality of conductor wires and, in one embodiment, thermally fusing the monofilament to the like material spacer by applying heat just below the melting temperature of the monofilament and spacer material. Alternatively, the monofilament and spacer may be of different materials and heat is applied to cause at least one material to thermally reflow or melt. The conductive contacts may be located at either the distal end and/or proximal end of the lead. Oversized spacers may be used in order to provide extra material to fill voids during the thermal fusion/reflow process.
    Type: Grant
    Filed: June 27, 2017
    Date of Patent: January 30, 2024
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Janusz A. Kuzma, Anne Margaret Pianca
  • Patent number: 11865345
    Abstract: A system for use with a neurostimulator coupled to one or more electrodes implanted adjacent neural tissue of a patient. The system comprises a user input device configured for allowing a user to select different nerve fiber diameters and to select a set of stimulation parameters. The system further comprises processing circuitry configured estimating regions of activation within the neural tissue of the patient based on the selected nerve fiber diameters and the selected stimulation parameter set. The system further comprises a display device configured for displaying the estimated regions of tissue activation. The user input device may further be configured for allowing the user to select different tissue regions of therapy, in which case, the display device may display the different tissue region on a human body map, and different indicia associating the displayed tissue regions for therapy to displayed estimated regions of tissue activation.
    Type: Grant
    Filed: May 9, 2022
    Date of Patent: January 9, 2024
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Dongchul Lee, Changfang Zhu
  • Patent number: 11865347
    Abstract: A system for an neurostimulator coupled to electrodes. The system comprises a input device configured for generating directional control signals, and memory storing ideal multipole configurations.
    Type: Grant
    Filed: January 5, 2021
    Date of Patent: January 9, 2024
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventor: Dongchul Lee
  • Patent number: 11857794
    Abstract: This document discusses, among other things, systems and methods for managing pain of a subject. A system includes one or more physiological sensors configured to sense a physiological signal indicative of patient brain activity. The physiological signals may include an electroencephalography signal, a magnetoencephalography signal, or a brain-evoked potential. The system may extract from the brain activity signal one or more signal metrics indicative of strength or pattern of brain electromagnetic activity associated with pain, and generate a pain score using the one or more signal metrics. The pain score can be output to a patient or a process. The system may select an electrode configuration for pain-relief electrostimulation based on the pain score, and deliver a closed-loop pain therapy according to the selected electrode configuration.
    Type: Grant
    Filed: December 8, 2022
    Date of Patent: January 2, 2024
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Elizabeth Mary Annoni, Jianwen Gu, Rosana Esteller, Bryan Allen Clark, Pramodsingh Hirasingh Thakur, Kyle Harish Srivastava
  • Patent number: 11850426
    Abstract: Software for providing a Graphical User Interface (GUI) for use in a clinician programmer for programming an implantable pulse generator (IPG) or external trial stimulator (ETS) is disclosed. A user may define in the GUI multiple pole configurations (e.g., monopoles, bipoles, etc.) which may be used independently to provide stimulation to a patient via the IPG or ETS's electrode array. Selected of the pole configurations can be linked or associated as a group in the GUI and used to concurrently provide stimulation. The pole configuration group may be steered or moved in the electrode array using a single movement instruction which moves all pole configurations in the group simultaneously. This allows the relative positions of the pole configurations in the group to remain constant as the group is moved.
    Type: Grant
    Filed: February 2, 2022
    Date of Patent: December 26, 2023
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Michael A. Moffitt, Que T. Doan
  • Patent number: 11850418
    Abstract: A system and method for extracting a cardiac signal from a spinal signal include measuring a spinal signal at one or more electrodes that are connected to a neurostimulator and implanted within a patient's spinal canal and processing the spinal signal to extract the cardiac signal, which includes features that are representative of the patient's cardiac activity. Processing the spinal signal to extract the cardiac signal can include filtering the spinal signal, or use of model reduction schemes such as independent component analysis. The extracted cardiac signal can include a number of features that correspond to an electrocardiogram and can be used to determine the patient's heart rate and/or to detect a cardiac anomaly. Cardiac features that are determined from the cardiac signal can additionally be used to adjust parameters of the stimulation that is provided by the neurostimulator.
    Type: Grant
    Filed: December 20, 2022
    Date of Patent: December 26, 2023
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Rosana Esteller, Deepa Mahajan, Bhaskar Sen, Tianhe Zhang
  • Patent number: 11844947
    Abstract: New waveforms for use in an implantable pulse generator or external trial stimulator are disclosed which mimic actively-driven biphasic pulses, and which are particularly useful for issuing low frequencies pulses. The waveforms comprise at each electrode interleaved first and second pulses. Each first pulse comprises a first monophasic pulse and a first passive charge recovery period. Each second pulse comprises a second monophasic pulse with a polarity opposite the first monophasic pulse and a second passive charge recovery period. Preferably, the amplitudes and pulse widths of the first and second monophasic pulses are equal, or at least charge balanced at each electrode. The first and second monophasic pulses mimic the functionality of a symmetric biphasic pulse, with the first monophasic pulse mimicking the functionality of the biphasic pulse's first phase, and the with the second monophasic pulse mimicking the functionality of the biphasic pulse's second phase.
    Type: Grant
    Filed: January 13, 2020
    Date of Patent: December 19, 2023
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Que T. Doan, Luca Antonello Annecchino, Ismael Huertas Fernandez
  • Patent number: 11833357
    Abstract: Techniques for pairing an external device such as a clinician programmer (CP) to an implantable medical device (IMD) are disclosed, which involve use of a remote controller (RC) paired to the IMD. The RC is placed into a CP pairing mode, which acts differently depending on the type of IMD paired to the RC. If the IMD is RF based, the CP pairing mode places the IMD in a pairing mode, thus allowing the CP to connect directly with the IMD via a RF telemetry protocol. If the IMD is magnetic-induction based, the CP pairing mode causes the RC to advertise its presence to the CP, allowing the CP to connect to the RC via the RF telemetry protocol. Because the RC is also paired with the IMD via a magnetic induction telemetry protocol, the RC acts as a passthrough device to allow communications between the CP and the IMD.
    Type: Grant
    Filed: December 20, 2022
    Date of Patent: December 5, 2023
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Chirag Shah, Peter Yoo
  • Patent number: 11833355
    Abstract: Systems and techniques are disclosed to generate programming parameters and modifications during closed-loop adjustment of an implantable neurostimulation device treatment programming, through the identification and application of weights determined from user input indications and rankings of therapy objectives.
    Type: Grant
    Filed: August 25, 2022
    Date of Patent: December 5, 2023
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventor: Matthew Lee McDonald
  • Patent number: 11832807
    Abstract: A system and method for securing a medical implant within a patient includes disposing an anchor element around the implant, the anchor element including a pair of tabs each including an eyelet, and a flexible intermediate portion between the tabs, by positioning the implant within the intermediate portion and folding the anchor element such that the tabs contact one another. The anchor element is positioned at a desired implantation position with the tabs proximate soft tissue of the patient. The method further includes inserting a distal tip of a fixation element delivery tool through the eyelets and into the soft tissue, the fixation element including at least one tissue anchor and an adjustable suture arrangement coupled to the tissue anchor. The tissue anchor is deployed from the delivery tool and into the soft tissue of the patient. The delivery tool is withdrawn and the adjustable suture arrangement is tightened.
    Type: Grant
    Filed: September 29, 2021
    Date of Patent: December 5, 2023
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Lawrence W. Wales, Jeffrey J. Peters, Vic Fabano, Ishmael Bentley
  • Patent number: 11826570
    Abstract: Systems and techniques are disclosed to adjust programming of an implantable electrical neurostimulation device for treating chronic pain of a human subject, through the use of a dynamic model adapted to identify pain treatment parameters for a human patient and determine a best device operational program to implement the pain treatment parameters to address the chronic pain condition. In an example, the system to adjust programming of the neurostimulation device performs operations that: obtain data related to a state of pain of the human subject; identify pain treatment parameters using a dynamic model adapted to evaluate the pain treatment parameters in the human subject over a time period, based on the data related to the state of pain; and select a neurostimulation program for the neurostimulation device, corresponding to at least a portion of the identified pain treatment parameters.
    Type: Grant
    Filed: June 23, 2022
    Date of Patent: November 28, 2023
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Qinghuang Lin, Jeffrey Rogers, Giovanni Russo, Andrea Simonetto, Tigran Tchrakian
  • Patent number: 11826573
    Abstract: Waveforms for a stimulator device, and methods and circuitry for generating them, are disclosed having high- and low-frequency aspects. The waveforms comprise a sequence of pulses issued at a low frequency which each pulse comprising first and second charge-balanced phases. One or both of the phases comprises a plurality a monophasic sub-phase pulses issued at a high frequency in which the sub-phase pulses are separated by gaps. The current during the gaps in a phase can be zero, or can comprise a non-zero current of the same polarity as the sub-phase pulses issued during that phase. The disclosed waveforms provide benefits of high frequency stimulation such as the promotion of paresthesia free, sub-threshold stimulation, but without drawbacks inherent in using high-frequency biphasic pulses.
    Type: Grant
    Filed: April 7, 2021
    Date of Patent: November 28, 2023
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Goran N. Marnfeldt, Kiran K. Gururaj, Rafael Carbunaru
  • Patent number: 11813458
    Abstract: Methods and systems are described for detecting if a stimulation lead implanted in a patient's brain has moved. Lead movement occurring between a first time and a second time may be determined by comparing features extracted from evoked potentials recorded at the two times. The disclosed methods and systems are particularly useful for determining if a stimulation lead has moved between the time it was implanted in the patient's brain and the time that stimulation parameters are being optimized. Lead movement during implantation, during parameter optimization, and during or between other lead optimization processes may be determined as well.
    Type: Grant
    Filed: March 7, 2022
    Date of Patent: November 14, 2023
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Rosana Esteller, Mahsa Malekmohammadi, Andrew Haddock, Tianhe Zhang
  • Patent number: 11818782
    Abstract: An advertising algorithm is disclosed which operates in an Implantable Medical Device (IMD) to adjust an interval at which the IMD will transmit advertising data packets to an external device able to connect with the IMD. When a communication session between the IMD and an external device is terminated, the advertising algorithm will issue advertising data packets at a higher rate for a set duration. This will allow the external device to connect more quickly with the IMD in a next communication session. After the set duration, when it may be assumed that the external device is less likely to connect with the IMD, the algorithm reduces that rate at which advertising data packets are issued, which saves power in the IMD.
    Type: Grant
    Filed: December 20, 2022
    Date of Patent: November 14, 2023
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Berj Doudian, Chirag Shah, Joshua Uyeda, Sridhar Kothandaraman, John Rivera, Damon Moazen